Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Chemotherapy in N2-3M0 Nasopharyngeal Carcinoma
NCT01694576Phase 2Terminated
- Sponsor
- Affiliated Cancer Hospital of Nanjing Medical University
- Start
- Sep 2012
- Primary completion
- Sep 2015
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, nedaplatin in nasopharyngeal carcinoma (NPC), sponsored by Affiliated Cancer Hospital of Nanjing Medical University. Started Sep 2012; status: terminated.
02
Drugs
paclitaxelnedaplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT01694576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01694576.